Annamaria Valentini

12PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersGene mappingCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 16, 2026
Biopsy-Based Molecular Signatures Predicting Therapeutic Response in Ulcerative Colitis.

|Oct 16, 2026
p38α Signaling Is Associated with Pancreatic Ductal Adenocarcinoma Progression and Represents a Potential Therapeutic Vulnerability.

|Jul 29, 2025
An Integrated Clinical, Germline, Somatic, and In Silico Approach to Assess a Novel PMS2 Gene Variant Identified in Two Unrelated Lynch Syndrome Families.

Candida Fasano, Antonia Lucia Buonadonna, Giovanna Forte

|Nov 09, 2024
Correction: Lepore Signorile et al. c-MYC Protein Stability Is Sustained by MAPKs in Colorectal Cancer. Cancers 2022, 14, 4840.

Martina Lepore Signorile, Valentina Grossi, Candida Fasano

|Oct 28, 2023
Tumor Testing and Genetic Analysis to Identify Lynch Syndrome Patients in an Italian Colorectal Cancer Cohort.

Antonino Pantaleo, Giovanna Forte, Filomena Cariola

|Oct 28, 2023
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment.

Annalisa Schirizzi, Aram Arshadi, Doron Tolomeo

Pageof 2

Frequent Collaborators

10 joint publications

Raffaele Armentano

3 joint publications

Grazia Serino

3 joint publications

Emanuele Piccinno

3 joint publications

Viviana Scalavino